|
1
|
Peng J, Xiao X, Hu M and Zhang X:
Interaction between gut microbiome and cardiovascular disease. Life
Sci. 214:153–157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nitsa A, Toutouza M, Machairas N, Mariolis
A, Philippou A and Koutsilieris M: Vitamin D in cardiovascular
disease. In Vivo. 32:977–981. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leong DP, Joseph PG, McKee M, Anand SS,
Teo KK, Schwalm JD and Yusuf S: Reducing the global burden of
cardiovascular disease, part 2: Prevention and treatment of
cardiovascular disease. Circ Res. 121:695–710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schaftenaar F, Frodermann V, Kuiper J and
Lutgens E: Atherosclerosis: The interplay between lipids and immune
cells. Curr Opin Lipidol. 27:209–215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barrington WT and Lusis AJ:
Atherosclerosis: Association between the gut microbiome and
atherosclerosis. Nat Rev Cardiol. 14:699–700. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He X, Lian Z, Yang Y, Wang Z, Fu X, Liu Y,
Li M, Tian J, Yu T and Xin H: Long Non-coding RNA PEBP1P2
suppresses proliferative VSMCs phenotypic switching and
proliferation in atherosclerosis. Mol Ther Nucleic Acids. 22:84–98.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu J, Zhang Y, You S, Guo Y, Chen S, Chang
Y, Zhang N and Sun Y: Paired box 9 regulates VSMC phenotypic
transformation, proliferation, and migration via sonic hedgehog.
Life Sci. 257:1180532020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu Y, Chang Y, Chen S, Li Y, Chen Y, Sun
G, Yu S, Ye N, Li C and Sun Y: BAG3 promotes the phenotypic
transformation of primary rat vascular smooth muscle cells via
TRAIL. Int J Mol Med. 41:2917–2926. 2018.PubMed/NCBI
|
|
9
|
Lu QB, Wan MY, Wang PY, Zhang CX, Xu DY,
Liao X and Sun HJ: Chicoric acid prevents PDGF-BB-induced VSMC
dedifferentiation, proliferation and migration by suppressing
ROS/NFĸB/mTOR/P70S6K signaling cascade. Redox Biol. 14:656–668.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang M, Li F, Wang X, Gong J, Xian Y,
Wang G, Zheng Z, Shang C, Wang B, He Y, et al: MiR-145 alleviates
Hcy-induced VSMC proliferation, migration, and phenotypic switch
through repression of the PI3K/Akt/mTOR pathway. Histochem Cell
Biol. 153:357–366. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song W, Gao K, Huang P, Tang Z, Nie F, Jia
S and Guo R: Bazedoxifene inhibits PDGF-BB induced VSMC phenotypic
switch via regulating the autophagy level. Life Sci.
259:1183972020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taniguti EH, Ferreira YS, Stupp IJV,
Fraga-Junior EB, Doneda DL, Lopes L, Rios-Santos F, Lima E, Buss
ZS, Viola GG and Vandresen-Filho S: Atorvastatin prevents
lipopolysaccharide-induced depressive-like behaviour in mice. Brain
Res Bull. 146:279–286. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li S, Yu Y, Jin Z, Dai Y, Lin H, Jiao Z,
Ma G, Cai W, Han B and Xiang X: Prediction of pharmacokinetic
drug-drug interactions causing atorvastatin-induced rhabdomyolysis
using physiologically based pharmacokinetic modelling. Biomed
Pharmacother. 119:1094162019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kogawa AC, Pires AEDT and Salgado HRN:
Atorvastatin: A review of analytical methods for pharmaceutical
quality control and monitoring. J AOAC Int. 102:801–809. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ginnan R, Sun LY, Schwarz JJ and Singer
HA: MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in
vascular smooth muscle cells. Biochem J. 444:105–114. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao G, Fu Y, Cai Z, Yu F, Gong Z, Dai R,
Hu Y, Zeng L, Xu Q and Kong W: Unspliced XBP1 Confers VSMC
homeostasis and prevents aortic aneurysm formation via FoxO4
Interaction. Circ Res. 121:1331–1345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang C, Huang W, Wang R and He Y:
Ulinastatin inhibits the proliferation, invasion and phenotypic
switching of PDGF-BB-Induced VSMCs via Akt/eNOS/NO/cGMP signaling
pathway. Drug Des Devel Ther. 14:5505–5514. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu W, Ni Z, Jiang S, Tong M, Zhang J, Zhao
J, Feng C, Jia Q, Wang J, Yao T, et al: Resveratrol inhibits bile
acid-induced gastric intestinal metaplasia via the PI3K/AKT/p-FoxO4
signalling pathway. Phytother Res. 35:1495–1507. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou N, Lee JJ, Stoll S, Ma B, Wiener R,
Wang C, Costa KD and Qiu H: Inhibition of SRF/myocardin reduces
aortic stiffness by targeting vascular smooth muscle cell
stiffening in hypertension. Cardiovasc Res. 113:171–182. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin X, Hou X, Zhang M, Liang T, Zhi J, Han
L and Li Q: Relaxation of rat aorta by farrerol correlates with
potency to reduce intracellular calcium of VSMCs. Int J Mol Sci.
15:6641–6656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tikoo K, Patel G, Kumar S, Karpe PA,
Sanghavi M, Malek V and Srinivasan K: Tissue specific up regulation
of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of
epigenetic histone modifications. Biochem Pharmacol. 93:343–351.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu LM, Wu SG, Chen F, Wu Q, Wu CM, Kang
CM, He X, Zhang RY, Lu ZF, Li XH, et al: Atorvastatin inhibits
pyroptosis through the lncRNA NEXN-AS1/NEXN pathway in human
vascular endothelial cells. Atherosclerosis. 293:26–34. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen S, Dong S, Li Z, Guo X, Zhang N, Yu B
and Sun Y: Atorvastatin calcium inhibits PDGF-ββ-induced
proliferation and migration of VSMCs Through the G0/G1 cell cycle
arrest and suppression of activated PDGFRbeta-PI3K-Akt signaling
cascade. Cell Physiol Biochem. 44:215–228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Blanco-Colio LM, Villa A, Ortego M,
Hernandez-Presa MA, Pascual A, Plaza JJ and Egido J:
3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors,
atorvastatin and simvastatin, induce apoptosis of vascular smooth
muscle cells by downregulation of Bcl-2 expression and Rho A
prenylation. Atherosclerosis. 161:17–26. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pietruczuk P, Jain A, Simo-Cheyou ER,
Anand-Srivastava MB and Srivastava AK: Protein kinase B/AKT
mediates insulin-like growth factor 1-induced phosphorylation and
nuclear export of histone deacetylase 5 via NADPH oxidase 4
activation in vascular smooth muscle cells. J Cell Physiol.
234:17337–17350. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okamoto H, Fujioka Y, Takahashi A,
Takahashi T, Taniguchi T, Ishikawa Y and Yokoyama M: Trichostatin
A, an inhibitor of histone deacetylase, inhibits smooth muscle cell
proliferation via induction of p21(WAF1). J Atheroscler Thromb.
13:183–191. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iaconetti C, De Rosa S, Polimeni A,
Sorrentino S, Gareri C, Carino A, Sabatino J, Colangelo M, Curcio A
and Indolfi C: Down-regulation of miR-23b induces phenotypic
switching of vascular smooth muscle cells in vitro and in vivo.
Cardiovasc Res. 107:522–533. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qu C, Liu X, Guo Y, Fo Y, Chen X, Zhou J
and Yang B: MiR-128-3p inhibits vascular smooth muscle cell
proliferation and migration by repressing FOXO4/MMP9 signaling
pathway. Mol Med. 26:1162020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong C, Ai J, Fan Y, Gao J, Liu W, Feng Q,
Liao W and Wu L: NCAPG promotes the proliferation of hepatocellular
carcinoma through PI3K/AKT signaling. Onco Targets Ther.
12:8537–8552. 2019. View Article : Google Scholar : PubMed/NCBI
|
